Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New app aims to ease overactive bladder without drugs or surgery

NCT ID NCT07206446

Symptom relief Sponsor: University of Galway Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a prescription smartphone app called RiSolve for women with overactive bladder (OAB). The app provides an 8-week program of bladder training, pelvic floor exercises, and digital cognitive behavioral therapy. Researchers enrolled 46 women in Ireland to see if the app is easy to use and helps reduce symptoms like urgency and leakage.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
RiSolve smartphone app (prescription digital therapeutic)
What this could lead to
If it works, this app could offer a convenient, accessible way for women to manage overactive bladder symptoms at home without medication or clinic visits.
What could go wrong
This is a small, single-arm study with only 46 participants, so results may not apply to everyone. The app is a digital tool, not a cure, and may not help severe cases.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

46 people

The number who actually took part.

Started

Oct 2025

Finished

Feb 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult women aged 18 and older with bothersome OAB symptoms: (i.e. must answer YES to one of the following): * Do you have a sudden need to rush to the toilet to urinate that is bothersome? OR * Does urine leak before you can get to the toilet? * Fluency and literacy in English to enable them to understand and complete treatment and required assessments * Currently based in the Republic of Ireland * Ownership and use of a smartphone * Use of at least one mobile App * Willing to forego commencing any other OAB treatments outside of RiSolve for the trial treatment period. Exclusion Criteria: * Current use of an anticholinergic/beta-agonist, within the previous two weeks and/or at the date of consenting * Currently using intermittent or indwelling catheter * Currently pregnant or planning pregnancy during the study treatment period * Currently receiving treatment for bladder/urethral, colon/anal, or cervical cancer * Voiding dysfunction (i.e. if Yes is an answer to any of the following): * Do you have pain in your bladder? OR * Do you have to strain to urinate? * Currently using sacral or tibial neuromodulation. * Has had intradetrusor therapy * Currently taking antibiotics/drugs for urinary tract infection * Planning surgery for pelvic organ prolapse within the trial treatment period * Planning to undergo pessary fitting during the study period (Note: patients with an existing pessary are eligible) within the trial treatment period * Visual impairment such that in the opinion of the PI would impair their use of the app

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Over active bladder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Alzheimer disease overactive bladder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Over active bladder Overactive bladder (OAB)

Contacts and locations

Locations

  • Primary Care Clinical Trial Network

    Galway, Ireland

More trials for these conditions

Other studies related to the condition(s) this trial covers.